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1. Introduction 
Malnutrition inevitably accompanies Chronic Kidney Disease (CKD) and dialysis. Markers 
of malnutrition like low serum albumin have been shown to correlate independently with 
higher mortality in dialysis patients (1).Malnutrition is seen in both Hemodiaysis (HD) and 
Peritoneal Dialysis (PD) patients. The incidence has been described at 10-70% in HD and 18-
51% in PD patients (2,3). The causes of malnutrition in dialysis patients can be manifold- 
dialysis factors, biochemical factors, gastrointestinal factors, miscellaneous factors, and low 
socio-economic status (4). Miscellaneous factors include depression, multiple medications, 
recurrent hospitalizations, and underlying illness. Modality of dialysis also affects 
nutritional status. There are factors unique to each both PD and HD that may contribute to 
the overall malnutrition. In PD, loss of albumin in PD fluid may range from 5.5-11.8 gms per 
day (5).In comparison, low flux dialysers account for amino acid losses of 5.6-7.1 gm/day in 
HD patients(6).Thus PD patients maintain lower serum albumin than age and weight 
controlled HD patients. Other causes responsible for hypoalbuminemia in PD patients 
include older age, etiology of renal failure, transport status, and chronic inflammation. 
Anorexia can result from distention due to fluid in the abdomen. Episodes of peritonitis can 
cause protein losses of upto 15 gm per day (7). Overhydration, and early satiety due to 
absorption of glucose from PD fluid can also be a cause of malnutrition in PD 
(8).Hospitalisation of dialysis patients is estimated to lead to them missing upto 20% of their 
lunches and dinners, with calorie deficits of upto 3000kcal/week (9).Other factors may 
ultimately impinge upon a dialysis patients nutritional well being. Blindness, amputations, 
dementia, depression and stroke are some factors adding to the nutritional challenges. 
Disabilities are more in HD patients than in PD, and is also more common in diabetics than 
non diabetics (10).As the number of diabetics on PD increased exponentially, malnutrition is 
also expected to increase with the same rate. Even though malnutrition is very common and 
strongly predicts outcome, malnutrition is not thought to directly cause death. Rather, a 
combination of malnutrition, inflammation and cardiovascular disease may be interrelated 
in dialysis (11,12). Serum levels of CRP and interleukin-6 (IL-6, which is a pivotal 
proinflammatory cytokine involved in systemic inflammation) were found to be 
significantly elevated in malnourished HD and PD patients. As a marker of systemic 
inflammatory reaction, serum CRP is now regarded as the best predictor for development of 
cardiovascular disease in the general population as well as in dialysis patients .These factors 
led to the proposal that malnutrition be characterised as Type1 and Type 2 (12).Type 1 
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malnutrition is related to the uremic syndrome per se and can be corrected by adequate 
dialysis. It is characterised by a normal/low serum albumin, absence of inflammation and 
comorbidity, low food intake and decreased protein catabolism. Type 2 malnutrition is 
thought to be ‘cytokine driven’ and is clinically more severe, characterised by 
hypoalbuminemia, inflammation, comorbidity  and increased protein catabolism. Thus, it is 
clear that malnutrition and co morbidities play a major role in determining outcomes in 
patients on PD. Assessment and treatment of nutritional problems in PD may lead to overall 
better performance on PD, better quality of life, and increased longevity. Methods of 
assessment of nutritional status, the interpretation and  limitations of the same, approaches 
towards the optimum treatment strategies, and future directions in the management of 
nutritional status in PD patients is dealt with  at length in this chapter in the following 
pages.  
2. Global perspective 
The prevalence of malnutrition in PD patients varies based upon the method of assessment 
used(13).For unclear reasons, longitudinal studies have shown that after initiation on PD, 
following an initial improvement, nutritional status gradually declines (14,15,16). There is 
clear  association between malnutrition and poor outcome in PD patients, but  the relevant 
studies including the much quoted CANUSA study (17) were based on Caucasian 
populations. It is not yet known whether the relationship is also applicable for Asian 
populations and whether Asian PD patients have distinct and unique nutritional issues 
compared to their Western counterparts. Also, it is not clear whether the reported  superior 
survival of Asian patients can be related to better preservation of nutritional status 
(18,19).There is a general feeling that the incidence of malnutrition is essentially similar in 
Western and Asian populations, but the incidence of severe malnutrition is lower in Asian 
populations (20,21,22,23). Lesser activation of a systemic inflammatory reaction 
in Asian PD patients is suggested, and that circumstance may partially explain their lower 
incidence of malnutrition as compared with Western PD patients(24)Lesser incidence of 
metabolic acidosis in Asian patients has also been reported (25). It appears that correction of 
metabolic acidosis improves the nutritional status of Asian PD patients, which is consistent 
with the results from earlier reports in Western PD patients. Reported data indicate that 
dietary protein and energy intakes are not much different, although actual dietary intake of 
nutrients is independently influenced by the delivered dialysis dose and RRF in Asian PD 
patients(26). The effect of peritoneal membrane transport characteristics on long-term 
nutritional status remains controversial (27).Establishing a relationship between dialysis 
adequacy and nutritional status (and clinical outcome) would give nutrition a central role 
and thus have important therapeutic implications. Important nutritional issues that need 
further investigation in Asian PD patients include determining daily diet requirements for 
maintenance of a positive nitrogen balance, establishing an optimum method to assess 
nutritional status, and developing preventive and therapeutic strategies to manage 
malnutrition. 
3. Indian scenario 
The lack of a Renal Registry system in India prevents an exact estimation of the incidence of 
renal failure and ESRD in India. Estimates suggest that an average of 160,000 new patients 
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require dialysis every year in India (28).Several problems mar the optimum use of PD in our 
patients. An initial prescription is usually limited to 3 exchanges of 2-L bags (29).Most 
patients are unable to afford 4 exchanges, or the use of newer/biocompatible solutions. 
Currently about 6000 patients are receiving PD in the country. Malnutrition in Indian 
patients is often severe and multifactorial. Reasons include late initiation of PD, protein 
restriction in the pre dialysis period, intercurrent infections, comorbidity, and dietary 
factors. Patients almost invariably fall short of recommended dietary intakes (30). The mean 
age of our CAPD patients is lower than that of PD patients in Western countries (31), and 
most of our PD patients are malnourished at  PD initiation (20). Comorbidities may also be 
different in Indian PD patients. Vegetarianism is very common in India which means that 
patients do not get animal source protein in their diet. Dietary habits in India are complex 
with many patients being pure vegetarians, some who occasionally partake of meat in the 
diet and some who are regular non vegetarians. This makes nutritional assessment and 
management difficult. Data on Indian patients nutritional status is scant. A recent trial 
showed that malnutrition at initiation of PD was predictive of higher incidence of 
peritonitis. Patients were categorized into malnourished or well-nourished groups on the 
basis of Subjective Global Assessment (SGA) scores. Malnourished patients experienced 
significantly more peritonitis episodes (1 vs. 0.2 annually) than did patients with a normal 
nutritional status. On univariate analysis, SGA, nutritional risk index, serum albumin, and 
daily calorie intake were significantly associated with peritonitis. On multivariate regression 
analysis, only SGA was a significant predictor of peritonitis. Peritonitis-free survival was 
better in patients showing normal nutrition than showing malnutrition (32).Indian PD 
patients are thought to consistently fail to achieve NKF-KDOQI recommended calorie and 
protein intake, which was confirmed in some Indian studies (31).There is an overall paucity 
of good data from India. Assessment of nutritional status, and the management of 
malnutrition, all remain suboptimal at present. 
4. Assessment of nutritional status in PD patients 
An ideal assessment of nutritional status of a patient draws from a detailed history, clinical 
examination including anthropometry and biochemical tests. There is no ideal and 100% 
effective method available at present. Current strategies of evaluating nutritional status vary 
from centre to centre and depend on many factors including economic considerations. In a 
country like India it is impossible to perform too frequent and cumbersome investigations 
especially when they are expensive. The different available tools for nutritional assessment 
are discussed here 
5. Subjective Global Assessment (SGA) 
This is probably the most widely used method of nutritional assessment. It is simple and 
inexpensive. It is based on the clinicians ability to make an assessment of the overall 
nutritional status based on a medical history and clinical examination, to derive a final score. 
In general, 60% of the clinician's rating of the patient is based on the results of the medical 
history, and 40% on the physical examination. The clinician rates each medical history and 
physical examination parameter as either an A, B, or C. Although originally used to 
categorize surgical patients, this nutritional classification system has been shown to be a 
reliable nutritional assessment tool for dialysis patients(14,33). SGA is limited by the very 
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fact that it is subjective and may not be entirely reproducible due to observer variability. In 
addition, its ability to detect small variations in nutritional status is limited. One parameter, 
the degree of anorexia, has been reported to be a strong predictor of mortality in 
haemodialysis patients [34]. 
6. Serum Albumin and Prealbumin 
Serum albumin has been, by far, the most commonly used marker of nutrition status in CKD 
patients, and it is a powerful predictor of mortality in PD patients (17).However Serum 
albumin as a marker of malnutrition has several caveats. The low serum albumin level 
observed in PD patients may reflect mostly the acute-phase response and resulting albumin 
losses in dialysate and urine, and only to a lesser extent poor nutrition status. The patient’s 
clinical status must be examined when evaluating changes in the serum albumin 
concentration, which is weakly and inversely correlated with serum acute phase proteins (35). 
Prealbumin is thought to be a better marker than serum albumin due to its shorter half life, 
and better correlation to the nutritional status. However Prealbumin is also a negative acute 
phase reactant (36).Also the prealbumin levels are related to the residual renal function 
(36,37).Hence both these markers may not be the ideal reflection of nutritional status. 
7. Serum Transferrin 
Serum Transferrin, though initially thought to reflect nutritional status, is now not widely 
used. It is almost universally low in dialysis patients and reflects iron status predominantly. 
8. Protein equivalent of total nitrogen appearance (nPNA) 
The use of nPNA as an estimate of protein intake is simple to use in the clinical setting. 
nPNA  approximates DPI only when the patient is in nitrogen equilibrium or steady state. It 
will change inanabolic or catabolic situations and needs to be interpreted accordingly. 
9. Anthropometry and hand grip strength  
The anthropometric parameters that are generally assessed include body weight, height, 
skeletal frame size, skin-fold thickness, midarm muscle circumference, percentage of the body 
mass that is fat, the percentage of usual body weight, the percentage of standard body weight 
and the body mass index (BMI) [38,39,40]. These various measures provide different 
information concerning body composition, and it is therefore advantageous to measure more 
than one of these parameters. Moreover these tests are cheap and easy to perform. There is 
focus on hand grip strength as a nutritional assessment tool as it has been demonstrated to 
predict mortality on PD patients (41).It is recommended to use some of these tests singly or in 
combination, for diagnosis of malnutrition and also for follow up of patients. 
10. Body composition measurements  
A-dual energy xray absorptiometry 
This is considered superior to other currently available techniques. With DEXA, bone 
mineral, fat mass (FM), and LBM distribution are estimated directly, without making 
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assumptions about the two-compartment model. However, the assessment of LBM by 
DEXA is subject to flaws, because it assumes that 72% of the LBM compartment is water. 
Given that PD patients can exhibit abnormal hydration status, DEXA might not be a very 
precise method for assessing LBM in dialyzed patients. Therefore, measurement of LBM by 
DEXA should be combined with estimation of the extracellular fluid volume by the tracer 
dilution technique. Provides accurate data on body composition which are superior to 
anthropometry, creatinine kinetics and bioelectrical impedance [42,43]. 
B-Bioimpedance Analysis (BIA) 
Bioimpedance analysis is based on the measurement of resistance and reactance when a 
constant alternating electrical current is applied to a patient, by empirical equations. 
However BIA is highly influenced by the hydration status .It is recommended that BIA be 
attempted only when the patient is at his oedema free weight. Our own experience with the 
use of BIA in CAPD patients showed good results (44).  
C-creatinine kinetics 
Creatinine kinetics is based on creatinine excretion in urine and dialysate. LBM estimated 
from creatinine kinetics depends on the creatinine content in the diet and the metabolic 
degradation of creatinine. Variations observed during repeated measures of LBM estimated 
using creatinine kinetics is unacceptably high (45). 
From the available tests we recommend relying on a panel of nutritional markers rather 
than any one particular test. We recommend assessment of nutritional status at least every 6 
months. Ideally, body weight, serum albumin, SGA, protein intake as assessed from dietary 
recall or nPNA, and an assessment of protein stores and iron stores (serum transferrin) 
would be necessary. A prospective decline in nutritional status would prompt a detailed 
evaluation. A cost effective but complete strategy for Indian patients would be a 6 monthly 
battery of tests that includes 
- Serum albumin 
- Serum Transferrin Saturation 
- SGA 
- Anthropometrics/Hand Grip Strength. 
While inexpensive, these tests would enable assessment of all necessary parameters. 
11. Nutritional intervention strategies 
It is important to individualise strategies for each patient rather than slavishly adhere to 
guidelines or formulae. Considerations towards cost, palatability, culture, and comorbidity 
should be considered. We recommend using the services of a renal dietician in addition to 
the expertise of the treating Physician. In consultation with the patient, a unique and 
exclusive plan is drawn up for each patient. 
12. Daily Protein Intake 
While a Daily Protein Intake(DPI) of 1.3g/kg/day is recommended, there is no conclusive 
evidence to show that lower protein intakes impact upon nutritional status in PD. Some 
studies have shown that a DPI of 1.0-1.2g/kg/day is adequate to maintain positive nitrogen 
balance (46,47). We would recommend a daily protein intake of > 1.0g/kg/day as sufficient 
if the patient has no declining trend in nutritional parameters. At a DPI of < 0.9g/kg/day, 
we would reassess the patients nutritional status. Our own experience with the use of 0.8 
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g/kg/day of protein, supplemented with keto analogues 0.4g/kg/day, when compared 
with a traditional protein diet of 1.2g/kg/day showed that the keto-group had 
improvement on parameters like appetite, anthropometry, serum albumin and a decrease in 
serum cholesterol and fasting blood sugar (48).  
 
MANAGEMENT OF MALNUTRITION IN PD PATIENTS- 
 
NON DIALYTIC MEASURES 
 Preserve residual renal function 
Prevent catabolic factors 
  Correct acidosis 
  Treat comorbidity and inflammation 
Maintain optimal nutrition 
  Nutritional counseling  
  Nutritional supplementation (oral, enteral, or parenteral ) 
Correct anemia 
Encourage exercise 
Emotional and social support 
DIALYSIS RELATED MEASURES 
Optimize dialysis dose 
Avoid potential sources of inflammation  
  during the PD procedure                                     
  Peritonitis 
  Bioincompatible PD solutions 
Attention to fluid, electrolyte and acid base balance. 
 Encourage anti-inflammatory diets 
NOVEL APPROACHES 
Use PD fluids with nutritional supplements         
Appetite stimulants 
Anti inflammatory diets 
  Dietary fibre, Phytoestrogens,Omega-3 fatty acids 
  Glycation End Product Inhibitor, PPAR-agonist, Antioxidants 
Table. 1. 
13. Dietary energy intake 
A dietary energy intake of > 35kcal/kg/day is essential for PD patients. In elderly patients 
30 kcal/kg/day may suffice. It is important to consider glucose absorption from the PD 
fluid. This can account for upto 100-200 g/24 hours. 
LIPIDS 
A diet with no more than 30% of total calories from fat should be encouraged. No more than 
10% should derive from saturated fat. 
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Complex carbohydrates are encouraged over refined carbohydrates. 
SODIUM AND WATER 
This is individualised based upon urine output, fluid status and blood pressure. We 
recommend 3-4 grams of salt intake /day in patients where ultrafiltration is easily achieved. 
POTASSIUM 
With residual renal function, we allow upto 100 meq/day of K unless the patient is on ACE 
inhibitors or ARBs. As dialysate contains no potassium, even in anuric PD patients we allow 
upto 100 meq/day. 
CALCIUM 
We attempt to achieve calcium balance with supplementation of calcium/ Vit D as needed. 
PHOSPHORUS  
Phosphorus restricted diets are often impractical to achieve as they lead to malnutrition. 
Ideally phosphorus intake should be limited to 0.6-1.2g/day. Most PD patients need the use 
of Phosphate binders. We target a serum phosphorus of 4.5-5.5 mg/dL. The choice of 
phosphate binders is individualised. 
IRON 
We target a serum transferring saturation of 20% or higher. We prefer the intravenous route 
of iron supplementation, for reasons of ease, compliance and effectiveness. 
14. Correction of metabolic acidosis  
Metabolic acidosis is an important stimulus for net protein catabolism and elicits the 
transcription of genes for proteolytic enzymes in muscle including the ubiquitin–
proteasome pathway. The correction of metabolic acidosis decreases protein degradation 
and improves nitrogen balance. This has been proven for PD patients (49).Oral sodium 
bicarbonate can be used to achieve this goal. 
15. Dose of dialysis 
The relationship between delivered dose of dialysis and nutrition is controversial. Overall, 
prospective studies of adequacy and nPNA or DPI have not shown any correlation. 
16. Additional nutritional support 
PD patients who may need additional support include patients with peritonitis, 
hospitalisation or gastroparesis. We recommend support with oral supplements of fortified 
energy and protein, intraperitoneal amino acids, nasogastric feeding or parenteral nutrition. 
17. Amino acid based PD fluids 
In a prospective, randomized, open-label study that evaluated the role of amino-acid  
dialysate on the nutrition status of malnourished PD patients, patients who replaced 1 daily 
exchange of traditional dialysate  with amino-acid dialysate showed better evolution in 
markers of nutrition than did patients who continued to use dextrose dialysate only(50). 
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18. Appetite stimulants 
The use of appetite stimulants such as megestrol acetate, cannabinoids, and cyproheptadine 
may be a tempting part of a new strategy for malnourished PD patients. Megestrol acetate 
has been suggested for use as an appetite stimulant in HD and PD patients (51,52); however, 
it is associated with several side effects, including hypogonadism, impotence, and increased 
risk of thromboembolism. 
ANTI INFLAMMATORY DIET 
A recent study with HD patients suggested a trend toward a reduction in the serum 
concentration of C-reactive protein (CRP) after 8 weeks’ ingestion of an isoflavone soy-based 
supplement(phytoestrogen based diet) (53).High fiber consumption in non-renal subjects 
was shown to lower the risk of elevated CRP (54). The anti-inflammatory effects of the 
omega-3 fatty acids, mainly eicosapentaenoic acid, found in fish oil are also well recognized. 
ANTI INFLAMMATORY PHARMACOTHERAPY 
This includes statins, ACEIs, PPAR agonists, and anti-oxidative agents, such as a- and g-
tocopherol. 
ANTICYTOKINE THERAPY 
These are still experimental.Interleukin-1 receptor antagonists are in trial. Recombinant 
insulin-like growth factor (rhIGF-1) may induce an anabolic response in patients in whom 
the primary cause of malnutrition is a low protein intake (55). 
19. Conclusions 
Nutritional management of PD patients is challenging, and vital to the patients long term 
survival and well being. A multi disciplinary approach, with a patient centric plan is 
necessary to achieve long term compliance and success. Consideration to cultural, economic 
and medical issues is paramount to develop a workable plan, especially in a country as large 
and diverse as India.  
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